IPM Technologies, Inc.

4134 North Vancouver Avenue, Suite 105
Portland, OR 97217
http://www.ipmtech.com
7 Employees

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.77MM
First Award Date 12/16/99
Most Recent Award Date 07/01/03

Key Personnel

Last Name Name Awards Contact
McLaughlin Dr. John McLaughlin 5 Message

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/03 - 06/30/05

DESCRIPTION (provided by applicant): IPM Technologies, Inc. will produce a formulation that will attract and kill nymphs and adults of the deer tick, Ixodes scapularis in the laboratory and in field trials. The target species, blacklegged tick transmits Lyme disease, two kinds of ehrlichiosis, and human babesiosis in the U.S. The project will id...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/02 - 06/30/03

DESCRIPTION (provided by applicant): IPM Technologies, Inc. will produce a formulation that will attract and kill nymphs and adults of the deer tick, Ixodes scapularis in the laboratory and in field trials. The target species, blacklegged tick transmits Lyme disease, two kinds of ehrlichiosis, and human babesiosis in the U.S. The project will id...

Phase 2 SBIR

Agency: Army
Topic: A99-066
Budget: 11/18/00 - 04/17/03

IPM Technologies, Inc. has successfully attained the objectives of Phase I research by producing a trial formulation containing a host-produced chemical that will attract adults of two species of medically important tick to a toxic attractant\acaricide matrix in laboratory bioassays. Ticks that contact the matrix become quickly intoxicated and ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/15/00 - 06/14/01

IPM Technologies will produce a formulation that will attract at least one active stage of a medically important tick to a toxic attractant/acaricide matrix in the laboratory, resulting in significant debilitation or death of the tick. The target species, blacklegged tick, transmits Lyme disease, two kinds of ehrlichiosis, and human babesiosis i...

Phase 1 SBIR

Agency: Army
Topic: A99-066
Budget: 12/16/99 - 12/17/00

IPM Technologies will produce a formulation that will attract at least one active stage of a medically important tick to a toxic attractant/acaricide matrix in the laboratory, resulting in significant debilitation or death of the tick. The target species, blacklegged tick, transmits Lyme disease, two kinds of ehrlichiosis, and human babesiosis...